← Latest papers
💻 bioinformatics

RICO enables integrated analysis of ribosomal DNA copy number and methylation from nanopore long-read sequencing

The paper introduces RICO, a novel computational pipeline that leverages Oxford Nanopore long-read sequencing to accurately and simultaneously quantify ribosomal DNA copy number and methylation, revealing a dosage compensation mechanism where higher copy numbers correlate with increased methylation to maintain stable active rDNA levels across individuals.

Original authors: Yuen, Z. W. S., Leeder, N., Udumanne, T., Garvie, A., Wong, L., Weiss, E., van Loon, L., Ganley, A., Hannan, R., Eyras, E., Hein, N.

Published 2026-11-10 (v2)
📖 6 min read🧠 Deep dive

Original authors: Yuen, Z. W. S., Leeder, N., Udumanne, T., Garvie, A., Wong, L., Weiss, E., van Loon, L., Ganley, A., Hannan, R., Eyras, E., Hein, N.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Inside every cell of the human body, tiny machines called ribosomes work tirelessly to build the proteins that keep us alive. These machines are constructed from a specific type of genetic instruction known as ribosomal RNA. The genes that hold these instructions are arranged in long, repeating chains, much like a necklace made of identical beads. Scientists have long known that the number of these beads varies wildly from person to person, with some individuals carrying a few hundred copies while others carry many more. This variation is significant because it is linked to aging, developmental disorders, and cancer, yet measuring it accurately has been nearly impossible. The repeating nature of the DNA makes it difficult for standard sequencing tools to count the copies without getting confused, and until now, researchers could not easily see how many of these copies were actually active versus how many were silenced and turned off.

A new study introduces a powerful new method called RICO, which allows scientists to count these genetic copies and check their activity status simultaneously. By using a type of DNA sequencing that reads long, continuous strands of genetic material, the researchers could map out the entire repeating chains without the confusion that plagues older methods. This approach revealed a surprising balance in the human genome: while the total number of ribosomal gene copies varies greatly between individuals, the number of active copies remains remarkably stable. It appears that the body uses an internal regulatory mechanism to adjust the activity of these genes, ensuring that everyone has a consistent supply of working ribosomes regardless of how many total copies they possess.

The challenge of studying these genes stems from their structure. In the human genome, the instructions for ribosomal RNA are organized into tandem arrays, where the same sequence is repeated hundreds of times in a row. Traditional sequencing methods break DNA into tiny fragments, which makes it difficult to determine how many repeats exist in a long chain, similar to trying to count the links in a long chain by looking at a pile of broken pieces. Furthermore, these genes are often chemically modified in a way that turns them off, a process known as methylation. Until now, scientists had to use different techniques to count the copies and to check which ones were turned on or off, making it hard to see the full picture of how these genes function in health and disease.

To solve this, the researchers developed a computational pipeline that analyzes long strands of DNA generated by Oxford Nanopore sequencing technology. This method produces reads that are long enough to span entire repeating units, allowing the software to count the copies directly. The team tested this system first on simulated data where the number of copies was known, confirming that the tool could accurately recover the correct counts. They then applied it to real human samples, including families with known genetic backgrounds, and found that the results were highly consistent across different sequencing runs. The method proved robust enough to detect known biological changes, such as a significant drop in gene copies in mouse cells where a specific tumor-suppressor gene had been removed, matching previous findings from other techniques.

One of the most striking discoveries came from analyzing the chemical state of these genes. The researchers found that in cells where the ribosomal genes were heavily methylated, the genes were effectively silenced and not producing RNA. By combining the copy count with the methylation data, they could estimate how many copies were actually active. When they looked at a large group of individuals, a clear pattern emerged: people with a very high total number of ribosomal gene copies tended to have a smaller fraction of those copies active. Conversely, individuals with fewer total copies had a larger fraction of them active. This inverse relationship suggests a dosage compensation mechanism, where the body adjusts the activity level of the genes to maintain a steady pool of working ribosomes, regardless of the total number of copies available.

This balancing act was observed across diverse human populations, including groups with different ancestral backgrounds, indicating that it is a fundamental feature of human biology. The study also validated these findings in mouse models of disease. In one model involving a specific type of lymphoma, the cancer cells showed an increase in the number of active ribosomal genes, consistent with the high demand for protein production in rapidly dividing cells. In another model where a key regulatory gene was missing, the total number of gene copies dropped, and the number of active copies dropped in tandem, confirming that the loss of this gene directly impacts the functional pool of ribosomes.

The ability to measure both the quantity and the activity of these genes in a single assay provides a more complete view of how the genome is regulated. The researchers noted that while the total number of copies can vary by hundreds, the estimated number of active copies in the specific human trio samples they studied remained within a much narrower range, typically between 90 and 120 copies per cell. This suggests that the body prioritizes maintaining a stable capacity for protein synthesis over the total genetic inventory. The findings challenge the idea that having more copies of these genes always means more activity, showing instead that the cell carefully manages which copies are used.

The study concludes that this integrated approach offers a scalable framework for investigating how genetic and epigenetic variations contribute to disease. By providing a reliable way to count these difficult-to-measure genes and assess their state, the new method opens the door to understanding why variations in ribosomal DNA are linked to conditions like cancer and aging. The researchers emphasize that while the total number of copies is a form of structural variation, the epigenetic state of those copies is what ultimately determines their function. This insight helps explain why individuals with vastly different total copy numbers can remain healthy, as their cells likely maintain a similar number of active, working genes through this compensatory mechanism.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →